Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.14670/HH-18-286

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorSong, Shunchen-
dc.contributor.authorGao, Yaxuan-
dc.contributor.authorSheng, Yi-
dc.contributor.authorRui, Tongyu-
dc.contributor.authorLuo, Chengliang-
dc.date.accessioned2023-01-11T10:01:18Z-
dc.date.available2023-01-11T10:01:18Z-
dc.date.issued2021-
dc.identifier.citationHistology and Histopathology Vol. 36, nº4 (2021)es
dc.identifier.issn0213-3911-
dc.identifier.issn1699-5848-
dc.identifier.urihttp://hdl.handle.net/10201/127106-
dc.description.abstracty. Brain injury is accompanied by serious iron metabolism disorder and oxidative stress. As a novel form of regulated cell death (RCD) depending on lipid peroxidation caused by iron overload, ferroptosis (FPT) further aggravates brain injury, which is different from apoptosis, autophagy and other traditional cell death in terms of biochemistry, morphology and genetics. Noteworthy, transcriptional regulator NRF2 plays a key role in the cell antioxidant system, and many genes related to FPT are under the control of NRF2, including genes for iron regulation, thiol-dependent antioxidant system, enzymatic detoxification of RCS and carbonyls, NADPH regeneration and ROS sources from mitochondria or extra-mitochondria, which place NRF2 in the key position of regulating the ferroptotic death. Importantly, NRF2 can reduce iron load and resist FPT. In the future, it is expected to open up a new way to treat brain injury by targeting NRF2 to alleviate FPT in brain.es
dc.formatapplication/pdfes
dc.format.extent15es
dc.languageenges
dc.publisherUniversidad de Murcia, Departamento de Biologia Celular e Histiologiaes
dc.relationSin financiación externa a la Universidades
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectNuclear Factor Erythroides
dc.subjectRelated Factores
dc.subject(NRF2)es
dc.subjectBrain Injuryes
dc.subjectFerroptosis (FPT)es
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncologíaes
dc.titleTargeting NRF2 to suppress ferroptosis in brain injury-
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doihttps://doi.org/10.14670/HH-18-286-
Aparece en las colecciones:Vol.36, nº4 (2021)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Song-36-383-397-2021.pdf4,66 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons